Phase 2, multicenter, safety and efficacy study of pidilizumab in patients with metastatic melanoma.
Michael B. Atkins
Expert Testimony - CureTech
Ragini Reiney Kudchadkar
No relevant relationships to disclose
Mario Sznol
No relevant relationships to disclose
David F. McDermott
Expert Testimony - CureTech
Michal Lotem
No relevant relationships to disclose
Jacob Schachter
Expert Testimony - CureTech
Jedd D. Wolchok
No relevant relationships to disclose
Walter John Urba
No relevant relationships to disclose
Timothy Kuzel
No relevant relationships to disclose
Lynn Mara Schuchter
No relevant relationships to disclose
Craig L. Slingluff
No relevant relationships to disclose
Marc S. Ernstoff
No relevant relationships to disclose
Joseph W. Fay
No relevant relationships to disclose
Philip Adam Friedlander
No relevant relationships to disclose
Thomas Gajewski
No relevant relationships to disclose
Hassane M. Zarour
No relevant relationships to disclose
Rinat Rotem-Yehudar
Employment or Leadership Position - CureTech
Jeffrey Alan Sosman
No relevant relationships to disclose